{"name":"BrainCells Inc.","slug":"braincells-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BCI-1038, BCI-1206 & BCI-1283","genericName":"BCI-1038, BCI-1206 & BCI-1283","slug":"bci-1038-bci-1206-bci-1283","indication":"Other","status":"phase_1"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"BCI-540","genericName":"BCI-540","slug":"bci-540","indication":"Major depressive disorder","status":"phase_2"}]}],"pipeline":[{"name":"BCI-1038, BCI-1206 & BCI-1283","genericName":"BCI-1038, BCI-1206 & BCI-1283","slug":"bci-1038-bci-1206-bci-1283","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BCI-540","genericName":"BCI-540","slug":"bci-540","phase":"phase_2","mechanism":"BCI-540 is a small molecule that modulates the activity of GABA_A receptors.","indications":["Major depressive disorder","Generalized anxiety disorder"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNWVE2MVlFbU9mc0U5ZjZZVmFRbEY5U053M2V3VVpGQUJNeUtHRTlKTGE4UkowVFNZbG9DVUh4dEszVm1yMnY0RXhoeHhVa2Y3N08waFpPUnNueFNzZS16QXJtOTNOM3cwemU1MXA1OEx2TlNoMVVBQV80SDZ1ME1PeUIxeW8xb3lBX0EzQ0I2YnNLZTVNZVpJbDdnUWQ3RjFDUmdXSnpjTQ?oc=5","date":"2026-02-12","type":"pipeline","source":"Forbes","summary":"This Startup Is Boosting AI With Real Brain Cells - Forbes","headline":"This Startup Is Boosting AI With Real Brain Cells","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTFA4bnZWbW5LRkF4bGc5RHJxbU50WHFwdmlvM0ZtNUJ5S1NMRTV3UWhUQ2JYSkxTQXNndlVjQmxQM041RjI3SHEzemdEamtYcEtDdEVkUXpiXzZwTWlMUXV0VjdfZnZnMzRt?oc=5","date":"2025-09-04","type":"trial","source":"Wiley Online Library","summary":"Do Patients Comply With 12‐h Lithium Blood Level Timing? Findings From a Controlled Clinical Trial and a Real‐World Clinical Setting - Jacobsen - Bipolar Disorders - Wiley Online Library","headline":"Do Patients Comply With 12‐h Lithium Blood Level Timing? Findings From a Controlled Clinical Trial and a Real‐World Clin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE1LM3dIS3BINnBkQlF6Zl9wNTBpb3pZLU5QbFV4MGVnZTd1aU4tZ1Jsc1Ntd0hvWWlpU1lvam1nR0lyM1RFUFN0S2FORHYwVExDeVctMFlMUWg0ODBBdkhDeFhB?oc=5","date":"2020-07-30","type":"pipeline","source":"Pharmaceutical Executive","summary":"Luca Santarelli, Roche - Pharmaceutical Executive","headline":"Luca Santarelli, Roche","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPak9sUWwyZm9CX2stcHF4bmhnQS0wS3Rubkk3bzZ4dElkV2FNZXllMHAwOGdQa2lBYkQzRFFMNFc3Vk5nZ29aR1ZjNTA0V3cteUMybzFuZFNOOUZNTFQ1SnV2dERzbnlQd1FNcUhyd0Vqajhud2RQN0x2V1VyNGxrUTJRVmN0Wi1oczZn?oc=5","date":"2020-02-21","type":"pipeline","source":"University of California, Berkeley","summary":"Brain cells protect muscles from wasting away - University of California, Berkeley","headline":"Brain cells protect muscles from wasting away - University of California, Berkeley","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxNZkI4NzlZc293T2NnTDZuT3JQd3RUUmN3NTh2OGd5RlNZTFpHXzBHV2thMWJfYUZoZE55eWJEd0ZwNWNQQncwa01RNF9ldHgyX3FUSlFyMFRUWkZFeFVTcXljMkZ2UjNmcmQwQVdpcDktcDFHM1cyOXFqR00xeUJSb3hQclg5VTNkOG12NUR2RFNZaWxlUTBhMzZnaGVOei1wOU5IRjM4Z0MyMGw1bVE?oc=5","date":"2013-01-23","type":"pipeline","source":"San Diego Union-Tribune","summary":"Science and music balance the busy world of CEO Harry Hixson - San Diego Union-Tribune","headline":"Science and music balance the busy world of CEO Harry Hixson - San Diego Union","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}